Cargando…

A Comprehensive Network Pharmacology-Based Strategy to Investigate Multiple Mechanisms of HeChan Tablet on Lung Cancer

BACKGROUND: HeChan tablet (HCT) is a traditional Chinese medicine preparation extensively prescribed to treat lung cancer in China. However, the pharmacological mechanisms of HCT on lung cancer remain to be elucidated. METHODS: A comprehensive network pharmacology-based strategy was conducted to exp...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhuang, Zhenjie, Chen, Qianying, Huang, Cihui, Wen, Junmao, Huang, Haifu, Liu, Zhanhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7277035/
https://www.ncbi.nlm.nih.gov/pubmed/32595734
http://dx.doi.org/10.1155/2020/7658342
_version_ 1783543033801736192
author Zhuang, Zhenjie
Chen, Qianying
Huang, Cihui
Wen, Junmao
Huang, Haifu
Liu, Zhanhua
author_facet Zhuang, Zhenjie
Chen, Qianying
Huang, Cihui
Wen, Junmao
Huang, Haifu
Liu, Zhanhua
author_sort Zhuang, Zhenjie
collection PubMed
description BACKGROUND: HeChan tablet (HCT) is a traditional Chinese medicine preparation extensively prescribed to treat lung cancer in China. However, the pharmacological mechanisms of HCT on lung cancer remain to be elucidated. METHODS: A comprehensive network pharmacology-based strategy was conducted to explore underlying mechanisms of HCT on lung cancer. Putative targets and compounds of HCT were retrieved from TCMSP and BATMAN-TCM databases; related genes of lung cancer were retrieved from OMIM and DisGeNET databases; known therapeutic target genes of lung cancer were retrieved from TTD and DrugBank databases; PPI networks among target genes were constructed to filter hub genes by STRING. Furthermore, the pathway and GO enrichment analysis of hub genes was performed by clusterProfiler, and the clinical significance of hub genes was identified by The Cancer Genome Atlas. RESULT: A total of 206 compounds and 2,433 target genes of HCT were obtained. 5,317 related genes of lung cancer and 77 known therapeutic target genes of lung cancer were identified. 507 unique target genes were identified among HCT-related genes of lung cancer and 34 unique target genes were identified among HCT-known therapeutic target genes of lung cancer. By PPI networks, 11 target genes AKT1, TP53, MAPK8, JUN, EGFR, TNF, INS, IL-6, MYC, VEGFA, and MAPK1 were identified as major hub genes. IL-6, JUN, EGFR, and MYC were shown to associate with the survival of lung cancer patients. Five compounds of HCT, quercetin, luteolin, kaempferol, beta-sitosterol, and baicalein were recognized as key compounds of HCT on lung cancer. The gene enrichment analysis implied that HCT probably benefitted patients with lung cancer by modulating the MAPK and PI3K-Akt pathways. CONCLUSION: This study predicted pharmacological and molecular mechanisms of HCT against lung cancer and could pave the way for further experimental research and clinical application of HCT.
format Online
Article
Text
id pubmed-7277035
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-72770352020-06-25 A Comprehensive Network Pharmacology-Based Strategy to Investigate Multiple Mechanisms of HeChan Tablet on Lung Cancer Zhuang, Zhenjie Chen, Qianying Huang, Cihui Wen, Junmao Huang, Haifu Liu, Zhanhua Evid Based Complement Alternat Med Research Article BACKGROUND: HeChan tablet (HCT) is a traditional Chinese medicine preparation extensively prescribed to treat lung cancer in China. However, the pharmacological mechanisms of HCT on lung cancer remain to be elucidated. METHODS: A comprehensive network pharmacology-based strategy was conducted to explore underlying mechanisms of HCT on lung cancer. Putative targets and compounds of HCT were retrieved from TCMSP and BATMAN-TCM databases; related genes of lung cancer were retrieved from OMIM and DisGeNET databases; known therapeutic target genes of lung cancer were retrieved from TTD and DrugBank databases; PPI networks among target genes were constructed to filter hub genes by STRING. Furthermore, the pathway and GO enrichment analysis of hub genes was performed by clusterProfiler, and the clinical significance of hub genes was identified by The Cancer Genome Atlas. RESULT: A total of 206 compounds and 2,433 target genes of HCT were obtained. 5,317 related genes of lung cancer and 77 known therapeutic target genes of lung cancer were identified. 507 unique target genes were identified among HCT-related genes of lung cancer and 34 unique target genes were identified among HCT-known therapeutic target genes of lung cancer. By PPI networks, 11 target genes AKT1, TP53, MAPK8, JUN, EGFR, TNF, INS, IL-6, MYC, VEGFA, and MAPK1 were identified as major hub genes. IL-6, JUN, EGFR, and MYC were shown to associate with the survival of lung cancer patients. Five compounds of HCT, quercetin, luteolin, kaempferol, beta-sitosterol, and baicalein were recognized as key compounds of HCT on lung cancer. The gene enrichment analysis implied that HCT probably benefitted patients with lung cancer by modulating the MAPK and PI3K-Akt pathways. CONCLUSION: This study predicted pharmacological and molecular mechanisms of HCT against lung cancer and could pave the way for further experimental research and clinical application of HCT. Hindawi 2020-05-30 /pmc/articles/PMC7277035/ /pubmed/32595734 http://dx.doi.org/10.1155/2020/7658342 Text en Copyright © 2020 Zhenjie Zhuang et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Zhuang, Zhenjie
Chen, Qianying
Huang, Cihui
Wen, Junmao
Huang, Haifu
Liu, Zhanhua
A Comprehensive Network Pharmacology-Based Strategy to Investigate Multiple Mechanisms of HeChan Tablet on Lung Cancer
title A Comprehensive Network Pharmacology-Based Strategy to Investigate Multiple Mechanisms of HeChan Tablet on Lung Cancer
title_full A Comprehensive Network Pharmacology-Based Strategy to Investigate Multiple Mechanisms of HeChan Tablet on Lung Cancer
title_fullStr A Comprehensive Network Pharmacology-Based Strategy to Investigate Multiple Mechanisms of HeChan Tablet on Lung Cancer
title_full_unstemmed A Comprehensive Network Pharmacology-Based Strategy to Investigate Multiple Mechanisms of HeChan Tablet on Lung Cancer
title_short A Comprehensive Network Pharmacology-Based Strategy to Investigate Multiple Mechanisms of HeChan Tablet on Lung Cancer
title_sort comprehensive network pharmacology-based strategy to investigate multiple mechanisms of hechan tablet on lung cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7277035/
https://www.ncbi.nlm.nih.gov/pubmed/32595734
http://dx.doi.org/10.1155/2020/7658342
work_keys_str_mv AT zhuangzhenjie acomprehensivenetworkpharmacologybasedstrategytoinvestigatemultiplemechanismsofhechantabletonlungcancer
AT chenqianying acomprehensivenetworkpharmacologybasedstrategytoinvestigatemultiplemechanismsofhechantabletonlungcancer
AT huangcihui acomprehensivenetworkpharmacologybasedstrategytoinvestigatemultiplemechanismsofhechantabletonlungcancer
AT wenjunmao acomprehensivenetworkpharmacologybasedstrategytoinvestigatemultiplemechanismsofhechantabletonlungcancer
AT huanghaifu acomprehensivenetworkpharmacologybasedstrategytoinvestigatemultiplemechanismsofhechantabletonlungcancer
AT liuzhanhua acomprehensivenetworkpharmacologybasedstrategytoinvestigatemultiplemechanismsofhechantabletonlungcancer
AT zhuangzhenjie comprehensivenetworkpharmacologybasedstrategytoinvestigatemultiplemechanismsofhechantabletonlungcancer
AT chenqianying comprehensivenetworkpharmacologybasedstrategytoinvestigatemultiplemechanismsofhechantabletonlungcancer
AT huangcihui comprehensivenetworkpharmacologybasedstrategytoinvestigatemultiplemechanismsofhechantabletonlungcancer
AT wenjunmao comprehensivenetworkpharmacologybasedstrategytoinvestigatemultiplemechanismsofhechantabletonlungcancer
AT huanghaifu comprehensivenetworkpharmacologybasedstrategytoinvestigatemultiplemechanismsofhechantabletonlungcancer
AT liuzhanhua comprehensivenetworkpharmacologybasedstrategytoinvestigatemultiplemechanismsofhechantabletonlungcancer